Abstract:e23123 Background: Pleural carcinosis caused by tumors of the chest (e.g., lung and breast cancer) or elsewhere in the body (e.g., ovarian carcinoma) that metastasize to the visceral and/or parietal pleura. Recurrent malignant pleural effusion due to pleural carcinosis is one of the most common findings in oncology. The aim of the study was to identify a miRNA signature associated with clinicians’ prescription of patients with MPE. Methods: We used qRT-PCR assay to evaluate a wide range miRNAs (1920 miRNAs) signature measured from pleural effusion between patients with cancer and healthy controls. From the data of our previous studies we selected a panel of 96 miRNAs related to malignant pleural effusion. Data were compared by three classification methods software for statistics and modeling. We used a first set of 77 pleural effusion samples as training group, including 27 patients affected by Lung Adenocarcinomas (LAC), 9 with other lung cancer, 17 with other tumors and 24 inflammatory patients as negative controls. Moreover, we used more 64 pleural effusion samples for double-blind predictive study. Data analysis was performed using a machine learning approach of a Support Vector Machine classifier with a Student's t-test feature selection procedure. Results: We identified a panel of ten miRNAs with optimum classification performance. The combination of these 10-miRNAs alone could discriminate MPE cases from negative controls with an AUC of 0.969 (accuracy = 93.5%; specificity = 91.7%). The selected panel of another 10-miRNAs could separate lung cancer cases from negative controls with an AUC of 0.973 (accuracy = 94.8%; specificity = 95.8%), and a small panel of 4-miRNAs could good discriminate LAC cases from negative controls with an AUC of 0.946 (accuracy 88.9%; specificity = 100%). The accuracy rate of the double-blind predictive sensitivity value was 90.9% and specificity value was 95.8% for MPE patients with lung cancer of miRNA signature. Conclusions: Our miRNAs profile may serve as a new biomarker for MPE diagnosis. Otherwise, we identified a 10-miRNAs signature for MPE patients with lung cancer and a 4-miRNAs for MPE patients with lung adenocarcinoma.

133 Distinctive Mirna Expression Profiles in Tissue and Serum of Primary Extramammary Pagets Disease

LB762 Distinctive Mirna Expression Profiles in Primary Extramammary Paget’s Disease

Mir-31 is Distinctively Overexpressed in Primary Male Extramammary Paget's Disease.

MiR-155, a Potential Serum Marker of Extramammary Paget's Disease.

Microarray-based Identification of Differentially Expressed Genes in Extramammary Paget's Disease.

Clinical Features and Follow Up Analysis of 19 Patients Wit Extramammary Paget Disease

Expression Profile And Clinical Significance Of Micrornas In Papillary Thyroid Carcinoma

Methylation and Expression Analysis of Mismatch Repair Genes in Extramammary Paget's Disease

Expression of Survivin and Human Telomerase Reverse Transcriptase in Extramammary Paget's Disease

Genetic Analysis of Mismatch Repair Genes Alterations in Extramammary Paget Disease.

Transcriptome sequencing reveals a lncRNA–mRNA interaction network in extramammary Paget’s disease

Genome-wide Microrna Expression Profiling in Malignant Pleural Effusion to Identify a Ten-Microrna Signature.

Extramammary Paget disease shows differential expression of B7 family members B7-H3, B7-H4, PD-L1, PD-L2 and cancer/testis antigens NY-ESO-1 and MAGE-A

Immunotherapy May Be More Appropriate for ERBB2 Low-Expressing Extramammary Paget’s Disease Patients: a Prognosis Analysis and Exploration of Targeted Therapy and Immunotherapy of Extramammary Paget’s Disease Patients

Oncogenic Mutations In Extramammary Paget'S Disease And Their Clinical Relevance

The Detection and Correlation Analysis of P16 and PCNA in Extramammary Paget′s Disease

Untargeted metabolomics yields insight into extramammary Paget's disease mechanisms

Untargeted Metabolomics Yields Insight into Extramammary Paget’s Disease Mechanisms

Whole genome methylation sequencing reveals epigenetic landscape and abnormal expression of FABP5 in extramammary Paget's disease

Association of EGFR Exon 19 Deletion and Mirna Expression in Lung Adenocarcinomas.

Clinical and Pathological Characteristics of Extramammary Paget's Disease: Report of 246 Chinese Male Patients.